Protogenix
Making animal protein ingredients safely in plants
- Founded
- 2021
- Employees*
- 4
- Funding to Date*
- $525,000
- Website
- proto-genix.com
"The science that lies behind Protogenix provides us with innovative approaches with which to address food insecurity on many levels. Reducing our reliance on animals will lower the carbon footprint associated with conventional food production."
Protogenix is focused the production of recombinant proteins for the cost-effective production of eukaryotic, complex, biologically active glycoproteins, including functional vaccine antigens and monoclonal antibodies (mAbs) without using mammalian cells. The company believes that its proprietary systems will deliver a step change in the cost, safety and speed of production for the healthcare, veterinary and food production industries.
More Companies